[SCHEDULE 13G/A] Pacific Biosciences of California, Inc. SEC Filing
Multiple related parties reported material holdings in Pacific Biosciences (PACB). Madrone Opportunity Fund directly holds 16,762,216 shares (5.6% of class) and Shimoda Holdings directly holds 3,500,000 shares (1.2%). Gregory Boyd Penner is reported as an individual with aggregate beneficial ownership of 20,262,216 shares (6.8% of class), reflecting his roles across the filing entities.
The filing discloses that the reported shares carry shared voting and shared dispositive power among the reporting persons and that the percentage figures are calculated using 300,084,685 shares outstanding as the denominator. The reporting persons expressly disclaim status as a "group."
Più soggetti correlati hanno dichiarato partecipazioni significative in Pacific Biosciences (PACB). Madrone Opportunity Fund detiene direttamente 16,762,216 azioni (5.6% della classe) e Shimoda Holdings detiene direttamente 3,500,000 azioni (1.2%). Gregory Boyd Penner risulta come individuo con una proprietà beneficiaria aggregata di 20,262,216 azioni (6.8% della classe), a riflesso dei suoi ruoli nelle entità che hanno presentato il deposito.
Il deposito indica che le azioni dichiarate attribuiscono poteri di voto condivisi e poteri di disposizione condivisi tra i soggetti che riportano e che le percentuali sono calcolate usando 300,084,685 azioni in circolazione come denominatore. I soggetti che riferiscono declinano espressamente lo status di "gruppo".
Varias partes relacionadas comunicaron participaciones significativas en Pacific Biosciences (PACB). Madrone Opportunity Fund posee directamente 16,762,216 acciones (5.6% de la clase) y Shimoda Holdings posee directamente 3,500,000 acciones (1.2%). Gregory Boyd Penner figura como individuo con propiedad beneficiaria agregada de 20,262,216 acciones (6.8% de la clase), reflejando sus funciones en las entidades que presentaron la declaración.
La presentación revela que las acciones reportadas conllevan poderes de voto compartidos y poderes de disposición compartidos entre las personas que informan y que los porcentajes se calculan usando 300,084,685 acciones en circulación como denominador. Las personas que informan declinan expresamente la condición de "grupo".
여러 ê´€ë � 당사ìžë“¤ì� Pacific Biosciences (PACB)ì—� 대í•� 중요í•� ë³´ìœ ë¥� ë³´ê³ í–ˆìŠµë‹ˆë‹¤. Madrone Opportunity FundëŠ� ì§ì ‘ 16,762,216ì£�(í´ëž˜ìŠ¤ì˜ 5.6%)ë¥� ë³´ìœ í•˜ê³ Shimoda HoldingsëŠ� ì§ì ‘ 3,500,000ì£�(1.2%)ë¥� ë³´ìœ í•©ë‹ˆë‹�. Gregory Boyd PennerëŠ� ì œì¶œ 주체들ì—ì„œì˜ ì—í• ì� ë°˜ì˜í•˜ì—¬ ì´ìˆ˜í˜œì ì†Œìœ ê¶Œì´ 20,262,216ì£�(í´ëž˜ìŠ¤ì˜ 6.8%)ë¡� ë³´ê³ ë˜ì–´ 있습니다.
ë³´ê³ ì„œì—ëŠ� ë³´ê³ ë� 주ì‹ë“¤ì´ ë³´ê³ ì¸ë“¤ 사ì´ì—� ê³µë™ ì˜ê²°ê¶� ë°� ê³µë™ ì²˜ë¶„ê¶�ì� 수반하며, ë¹„ìœ¨ì€ ë¶„ëª¨ë¡� 300,084,685ì£� ìœ í†µì£¼ì‹ì� 사용í•� 계산ë˜ì—ˆë‹¤ê³ 명시ë˜ì–´ 있습니다. ë³´ê³ ì¸ë“¤ì€ 명시ì 으ë¡� "그룹" 지위를 ë¶€ì¸í•©ë‹ˆë‹¤.
Plusieurs parties liées ont déclaré des participations importantes dans Pacific Biosciences (PACB). Madrone Opportunity Fund détient directement 16,762,216 actions (5.6% de la catégorie) et Shimoda Holdings détient directement 3,500,000 actions (1.2%). Gregory Boyd Penner est indiqué comme personne physique disposant d'une propriété bénéficiaire agrégée de 20,262,216 actions (6.8% de la catégorie), ce qui reflète ses rôles au sein des entités ayant déposé la déclaration.
La déclaration précise que les actions déclarées donnent lieu à droits de vote partagés et droits de disposition partagés entre les personnes déclarantes et que les pourcentages sont calculés en prenant 300,084,685 actions en circulation comme dénominateur. Les personnes déclarantes déclinent expressément le statut de "groupe".
Mehrere verbundene Parteien meldeten wesentliche Beteiligungen an Pacific Biosciences (PACB). Madrone Opportunity Fund hält direkt 16,762,216 Aktien (5.6% der Klasse) und Shimoda Holdings hält direkt 3,500,000 Aktien (1.2%). Gregory Boyd Penner wird als Einzelperson mit aggregiertem wirtschaftlichen Eigentum von 20,262,216 Aktien (6.8% der Klasse) ausgewiesen, was seine Rollen in den meldenden Einheiten widerspiegelt.
Die Meldung gibt an, dass die berichteten Aktien gemeinsame Stimmrechte und gemeinsame Verfügungsrechte unter den meldepflichtigen Personen aufweisen und dass die Prozentangaben mit 300,084,685 ausstehenden Aktien als Nenner berechnet werden. Die meldepflichtigen Personen lehnen ausdrücklich den Status einer "Gruppe" ab.
- Aggregate beneficial ownership disclosed: Gregory Penner reports 20,262,216 shares (6.8%) of PACB, a material position.
- Madrone Opportunity Fund transparency: Direct holding of 16,762,216 shares (5.6%) clearly reported.
- Clear voting/dispositive power disclosure: Filing states shared voting and shared dispositive power for reported positions.
- Percentage basis provided: Ownership percentages use 300,084,685 shares outstanding for calculation.
- None.
Insights
TL;DR: Combined holdings represent a meaningful >5% stake, with shared voting power across related entities.
The Schedule 13G/A shows clear, quantifiable positions: Madrone Opportunity Fund holds 16,762,216 shares (5.6%) and Shimoda holds 3,500,000 shares (1.2%), producing an aggregate beneficial ownership for Gregory Penner of 20,262,216 shares (6.8%). Reported authority is shared voting and shared dispositive power, which signals coordinated control over disposition and voting of these shares even as the filing explicitly disclaims group status. The percent basis is disclosed as 300,084,685 shares outstanding, giving clarity to the stake magnitude.
TL;DR: Managers and entities report overlapping authority; formal disclaimer of a "group" contrasts with shared powers disclosed.
The filing documents that Madrone GP, as general partner of Madrone Opportunity Fund, and managers (Penner, McJunkin, Patterson) share voting and investment authority over Madrone's 16,762,216-share position. Shimoda's 3,500,000-share position is managed in part by Penner. While the Reporting Persons "expressly disclaim" group status, the combination of shared voting and shared dispositive power is governance-relevant and amounts to a substantive disclosure for investors assessing potential influence on issuer decisions.
Più soggetti correlati hanno dichiarato partecipazioni significative in Pacific Biosciences (PACB). Madrone Opportunity Fund detiene direttamente 16,762,216 azioni (5.6% della classe) e Shimoda Holdings detiene direttamente 3,500,000 azioni (1.2%). Gregory Boyd Penner risulta come individuo con una proprietà beneficiaria aggregata di 20,262,216 azioni (6.8% della classe), a riflesso dei suoi ruoli nelle entità che hanno presentato il deposito.
Il deposito indica che le azioni dichiarate attribuiscono poteri di voto condivisi e poteri di disposizione condivisi tra i soggetti che riportano e che le percentuali sono calcolate usando 300,084,685 azioni in circolazione come denominatore. I soggetti che riferiscono declinano espressamente lo status di "gruppo".
Varias partes relacionadas comunicaron participaciones significativas en Pacific Biosciences (PACB). Madrone Opportunity Fund posee directamente 16,762,216 acciones (5.6% de la clase) y Shimoda Holdings posee directamente 3,500,000 acciones (1.2%). Gregory Boyd Penner figura como individuo con propiedad beneficiaria agregada de 20,262,216 acciones (6.8% de la clase), reflejando sus funciones en las entidades que presentaron la declaración.
La presentación revela que las acciones reportadas conllevan poderes de voto compartidos y poderes de disposición compartidos entre las personas que informan y que los porcentajes se calculan usando 300,084,685 acciones en circulación como denominador. Las personas que informan declinan expresamente la condición de "grupo".
여러 ê´€ë � 당사ìžë“¤ì� Pacific Biosciences (PACB)ì—� 대í•� 중요í•� ë³´ìœ ë¥� ë³´ê³ í–ˆìŠµë‹ˆë‹¤. Madrone Opportunity FundëŠ� ì§ì ‘ 16,762,216ì£�(í´ëž˜ìŠ¤ì˜ 5.6%)ë¥� ë³´ìœ í•˜ê³ Shimoda HoldingsëŠ� ì§ì ‘ 3,500,000ì£�(1.2%)ë¥� ë³´ìœ í•©ë‹ˆë‹�. Gregory Boyd PennerëŠ� ì œì¶œ 주체들ì—ì„œì˜ ì—í• ì� ë°˜ì˜í•˜ì—¬ ì´ìˆ˜í˜œì ì†Œìœ ê¶Œì´ 20,262,216ì£�(í´ëž˜ìŠ¤ì˜ 6.8%)ë¡� ë³´ê³ ë˜ì–´ 있습니다.
ë³´ê³ ì„œì—ëŠ� ë³´ê³ ë� 주ì‹ë“¤ì´ ë³´ê³ ì¸ë“¤ 사ì´ì—� ê³µë™ ì˜ê²°ê¶� ë°� ê³µë™ ì²˜ë¶„ê¶�ì� 수반하며, ë¹„ìœ¨ì€ ë¶„ëª¨ë¡� 300,084,685ì£� ìœ í†µì£¼ì‹ì� 사용í•� 계산ë˜ì—ˆë‹¤ê³ 명시ë˜ì–´ 있습니다. ë³´ê³ ì¸ë“¤ì€ 명시ì 으ë¡� "그룹" 지위를 ë¶€ì¸í•©ë‹ˆë‹¤.
Plusieurs parties liées ont déclaré des participations importantes dans Pacific Biosciences (PACB). Madrone Opportunity Fund détient directement 16,762,216 actions (5.6% de la catégorie) et Shimoda Holdings détient directement 3,500,000 actions (1.2%). Gregory Boyd Penner est indiqué comme personne physique disposant d'une propriété bénéficiaire agrégée de 20,262,216 actions (6.8% de la catégorie), ce qui reflète ses rôles au sein des entités ayant déposé la déclaration.
La déclaration précise que les actions déclarées donnent lieu à droits de vote partagés et droits de disposition partagés entre les personnes déclarantes et que les pourcentages sont calculés en prenant 300,084,685 actions en circulation comme dénominateur. Les personnes déclarantes déclinent expressément le statut de "groupe".
Mehrere verbundene Parteien meldeten wesentliche Beteiligungen an Pacific Biosciences (PACB). Madrone Opportunity Fund hält direkt 16,762,216 Aktien (5.6% der Klasse) und Shimoda Holdings hält direkt 3,500,000 Aktien (1.2%). Gregory Boyd Penner wird als Einzelperson mit aggregiertem wirtschaftlichen Eigentum von 20,262,216 Aktien (6.8% der Klasse) ausgewiesen, was seine Rollen in den meldenden Einheiten widerspiegelt.
Die Meldung gibt an, dass die berichteten Aktien gemeinsame Stimmrechte und gemeinsame Verfügungsrechte unter den meldepflichtigen Personen aufweisen und dass die Prozentangaben mit 300,084,685 ausstehenden Aktien als Nenner berechnet werden. Die meldepflichtigen Personen lehnen ausdrücklich den Status einer "Gruppe" ab.